期刊文献+

奥氮平、氟哌啶醇对精神分裂症病人血清催乳素和生长激素的影响 被引量:1

Effects of olanzapine and haloperidol on serum prolactin and growth hormone in schizophrenia patients
下载PDF
导出
摘要 目的:探讨精神分裂症病人催乳素(PRL)和生长激素(GH)的基础水平与正常人的差异,及奥氮平、氟哌啶醇治疗前后PRL,GH水平的变化。方法:采用放射免疫法测定61例精神分裂症病人治疗前和治疗8wk末的PRL和GH水平,并与30名健康者对照,同时将61例精神分裂症病人分为奥氮平治疗组28例和氟哌啶醇治疗组33例,观察药物对PRL和GH水平的影响。结果:精神分裂症病人的基础PRL,GH水平与对照组差异无显著意义(P>0.05);奥氮平组治疗8wk末PRL,GH均无显著改变(P>0.05);氟哌啶醇组治疗8wk末PRL值为(99±48)μg·L-1,较治疗前(17±10)μg·L-1显著增高(P<0.01),GH值为(1.6±1.4)μg·L-1,较治疗前(2.4±1.6)μg·L-1显著降低(P<0.01)。结论:精神分裂症病人PRL和GH的基础水平与正常群体差异不显著。奥氮平对PRL,GH无明显影响,氟哌啶醇致PRL升高,GH降低。 AIM:To find out if there was any difference of serum prolactin (PRL) and growth hormone (GH)levels between schizophrenics and normal control and to compare the changes of these two hormones after olanzapine and haloperidol treatment. METHODS : Radioimmunoassay (RIA) was used to examine serum levels of PRL and GH in 61 schizophrenics before and after 8 wk treatments. The 61 patients were divided to olanzapine group (28 patients ) and haloperidol group (33 patients ). The results before treatment were compared with those of the normal control. RESULTS:There were no differences of serum PRL level and GH level between schizophrenics before treatment and normal control ( P 〉 0.05 ). After treatment of antipsychotics, in the olanzapine group, there were no differences about PRL level and GH level before and after treatment. In the haloperidol group, after 8 wk treatment of haloperidol, the serum PRL level of patients was ( 99 ± 48 ) μg·L^-1, significantly higiler than (17 ± 10) μg·L^-1 before treatment (P 〈 0.01 ), the serum GH level of patients was (1.6 ±1.4) μg·L^-1, significantly lower than ( 2.4 ± 1.6 ) μg·L^-1before treatment ( P 〈 0.01 ). CONCLUSION:There are no difference of serum PRL level and GH level between schizophrenics before treatment and normal control. Olanzapine possesses no significant effects on serum levels of PRL and GH, but haloperidol shows effects on increase of PRL and decrease GH levels in serum.
出处 《中国新药与临床杂志》 CAS CSCD 北大核心 2005年第10期792-795,共4页 Chinese Journal of New Drugs and Clinical Remedies
基金 江苏省无锡市科技发展基金资助项目(CS030001)
关键词 精神分裂症 催乳素 生长激素(人) 奥氮平 氟哌啶醇 schizophrenia prolactin somatropin olanzapine haloperidol
  • 相关文献

参考文献9

  • 1HAMNER M. The effects of atypical antipsychotics on serum prolactin levels[J]. Ann Clin Psychiatry,2002,14(3 ) : 163-173.
  • 2喻东山,余琳.精神药物和高催乳素血症[J].中国新药与临床杂志,2004,23(12):893-896. 被引量:44
  • 3HENDERSON DC, GOFF DC, CONNLLY CE,et al. Risperidome added to olazapine:impait on serum prolactin levels[J]. J Clin Psychiatry,2001,62(8 ) :605-608.
  • 4徐贵云,侯静,马崔,吴福喜,黎德美,陆欣乔,朱海兵.利培酮与氟哌啶醇对女性首发精神分裂症患者血清催乳素水平的影响[J].中国神经精神疾病杂志,2001,27(6):454-455. 被引量:20
  • 5马文涛,杨来启,刘光雄,林玉梅,吴兴曲,邓自和.氯丙嗪和氯氮平对血清催乳素和生长素的影响[J].临床精神医学杂志,2000,10(6):323-325. 被引量:7
  • 6KAPUR S, ZIPURSKY RB, JONES C,et al. A position emission tomography study of quetiapine in schizophrenia : a preliminary finding of an antipsychotic effect with only transiently high dopamine D2 receptor occupancy [ J ]. Arch Gen Psychiatry, 2000,57 ( 6 ) : 553-554.
  • 7KAPUR S, SEEMAN P. Does fast dissociation from the dopamine d(2) receptor esplain the action of atypical antipsychotics? A new hypothesis [ J ]. Am J Psychiatry,2001,158 ( 3 ) :360-369.
  • 8沈渔屯.精神病学[M].北京:人民卫生出版社,2001.652-653.
  • 9LEE JH, WOO JI, MELTZER HY. Effects of clozapine on sleep measures and sleep - associated changes in growth hormone and cortisol in patients with schizophrenia[J]. Psychiatry Res, 2001, 103(2-3) :157-166.

二级参考文献24

  • 1孙士友,尚岚.精神分裂症药物治疗进展[J].国外医学(精神病学分册),1996,23(4):220-223. 被引量:5
  • 2张明园.简明精神病量表(BPRS)[J].上海精神医学,1990,2:2-2.
  • 3周衍椒 张镜如.生理学(第3版)[M].北京:人民卫生出版社,1989.297.
  • 4张逢春 张永芳 等.抗精神病药对精神分裂症患者的血清催乳素的作用探讨[J].中国神经精神疾病杂志,1986,2:80-80.
  • 5Breier A F,Am J Psychiatry,1999年,156卷,2期,294页
  • 6MAGUIRE GA. Prolactin elevation with antipsychotic medications: mechanisms of action and clinical consequences[J]. J Clin Psychiatry, 2002, 63 Suppl 4: 56-62.
  • 7MCINTYRE RS. Psychotropic drugs and adverse events in the treatment of bipolar disorders revisited[J]. J Clin Psychiatry, 2002,63 Suppl 3: 15-20.
  • 8WIRSHING DA, PIERRE JM, ERHART SM, et al. Understanding the new and evolving profile of adverse drug effects in schizophrenia[J]. Psychiat Clin North Am,2003,26(1):165-190.
  • 9NICHOLAS L, DAWKINS K, GOLGEN RN. Psychoneuroendocrinology of depression. Prolactin[J]. Psychiat Clin North Am, 1998,21(2):341-358.
  • 10WIECK A, HADDAD PM. Antipsychotic-induced hyperprolactinaemia in women: pathophysiology, severity and consequences[J]. Br J Psychiatry, 2003, 182(3):199-204.

共引文献71

同被引文献27

引证文献1

二级引证文献9

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部